Introduction
============

The hallmark of *Helicobacter pylori* infection is the development of gastric inflammation, referred to as gastritis. It is believed that all *H. pylori* infected individuals develop gastritis. In animal models of disease, the development of gastritis is dependent on the presence of T lymphocytes (T cells). Severe combined immunodeficiency mice, which lack B and T cells, require adoptive transfer of T cells to develop gastritis (Eaton et al., [@B14], [@B13]).

T cells play a decisive role in initiating and shaping pathological responses in many tissues. Classical examples of T-cell mediated diseases are inflammatory bowel disease (IBD), diabetes, psoriasis, rheumatoid arthritis, and multiple sclerosis. Interplay, between T cells and other immune and non-immune cells, is critical in driving pathologic processes, and T cell-derived cytokines are essential mediators of this cross-talk. CD4+ T cells were traditionally categorized as Th1 or Th2, but over the last decade, research has characterized a number of new distinct CD4+ T cell subsets including Th17 cells, T regulatory cells, T follicular helper cells (Tfh), and T helper-9 cells. A fundamental function of T helper cells is to provide "help" to B cells and regulate their proliferation and immunoglobulin class switching. But CD4+ cells do more than just help B cells; their cytokine production also regulates antimicrobial/antiviral responses. For example, IFNγ activates macrophages and stimulates CD8+ cytotoxic responses, while IL-17 induces neutrophil migration for clearance of extracellular pathogens, such as *H. pylori*. TGF-β, which can be produced by natural T~regs~, also controls inflammation by inducing Foxp3 expression in T helper cells stimulating the production of inducible T~regs~.

The development of the Th17 lineage may be important for the control of *H. pylori* infection and the development of gastritis during *H. pylori* infection. Induction of Th17 cells is attributed to several *H. pylori* factors including Urease B (Zhang et al., [@B47]). Several studies have indicated that *H. pylori* stimulated macrophages produce IL-6, TGF-β, IL-23, and CCL20 (Meyer et al., [@B31]; Mandell et al., [@B27]; Odenbreit et al., [@B33]; Zhuang et al., [@B48]).

The gastritis associated with *H. pylori* infection involves both acute and chronic inflammation suggesting that T cell derived cytokines such as those produced by Th17 cells may be responsible for the ongoing acute inflammatory response associated with the recruitment of neutrophils to the stomach. Th17 lineage develops in a pathway independent from Th1 and Th2 differentiation (Bettelli et al., [@B3]). A hallmark of Th17 cells is the production of IL-17, IL-21, and IL-22, which are pro-inflammatory cytokines. Th17 cells are known to have an important role in a growing list of immune-mediated diseases, including IBD, experimental autoimmune encephalopathy (EAE), and collagen-induced arthritis (CIA; reviewed in McKenzie et al., [@B29]; Furuzawa-Carballeda et al., [@B16]; Sarkar et al., [@B35]). In addition, in several animal models of infectious diseases, the IL-23/IL-17 axis promotes cell migration to the site of infection to kill microorganisms and activates the bactericidal activity of macrophages (reviewed in Curtis and Way, [@B10]). The host's ability to control the proliferation of *Klebsiella pneumoniae, Citrobacter rodentium, Mycoplasma pneumoniae, Bordetella pertussis, Pseudomonas aeruginosa, Porphyromonas gingivalis, Escherichia coli, Listeria monocytogenes, and* *Salmonella enterica* is at least partially dependent on IL-23 and IL-17 (Ye et al., [@B44]; Mangan et al., [@B28]; Chen et al., [@B6]; Dubin and Kolls, [@B12]; Shibata et al., [@B38]; Wu et al., [@B42]; Yu et al., [@B46]; Hamada et al., [@B18]; Schulz et al., [@B36]). Several studies from infection models in IL-23p19 deficient mice demonstrate IL-23 contributes to deficient neutrophil recruitment (Cruz et al., [@B9]; Meeks et al., [@B30]), reduction in IL-17 (Happel et al., [@B19]; Khader et al., [@B22]; Chackerian et al., [@B5]; Kleinschek et al., [@B23]; Schulz et al., [@B37]), increase in both disease susceptibility and organism burden in some infectious models (Happel et al., [@B19]; Khader et al., [@B22]; Meeks et al., [@B30]), whereas other animal models exhibit no differences in neither disease susceptibility nor organism burden (Khader et al., [@B22]; Chackerian et al., [@B5]; Schulz et al., [@B37]). IL-17 activates gastric epithelial cells to produce neutrophil attracting chemokines (Algood et al., [@B1]). In some studies, IL-17 is required for control of bacterial load, while in other studies it is only required for recruitment of neutrophils (Shiomi et al., [@B39]; Algood et al., [@B1]; DeLyria et al., [@B11]; Otani et al., [@B34]).

The development of a Th17 response is promoted by TGF-β, IL-1β, and IL-6 and further expanded and activated by IL-23. IL-23 is a heterodimer comprised of an IL-23p19 subunit and an IL-12p40 subunit. It is produced by a number of immune cells including macrophages, dendritic cells, and neutrophils. Broadly speaking, the function of IL-23 resembles the function of IL-12 in linking innate responses and adaptive immunity. IL-23 regulates the secretion of IL-17 through at STAT3 dependent pathway (Caruso et al., [@B4]). IL-23 induced activation of STAT3 leads to direct binding of phosphorylated STAT3 to IL-17A and IL-17F promoters (Chen et al., [@B8]). Moreover, STAT3 up-regulates the expression of Retinoic Acid Receptor-Related Orphan Receptor Gamma-T (ROR-γ), a Th17 specific transcriptional regulator that is critical for the expression of two members of IL-17A and IL-17F (Chen et al., [@B7]; Laurence and O'Shea, [@B26]; Yang et al., [@B43]).

Although IL-23 is a marker of *H. pylori* infection (Caruso et al., [@B4]), levels of IL-23 alone do not correlate with chronic gastritis, duodenal, or gastric ulcers (Koussoulas et al., [@B24]). However, positive correlations were found between levels of IL-23 and the degree of infiltration of neutrophils and monocytes in patients with *H. pylori* infection, and the kinetics of IL-23 expression correlates with those of IL-1β (Koussoulas et al., [@B24]).

In the current study, we investigated the role of IL-23p19 on the development of the Th17 and Th1 adaptive immune responses during *H. pylori* infection in a mouse model of infection. Moreover, this study investigates the requirement of IL-23p19 in the development of an effective immune response (control of *H. pylori* colonization) and the development of gastritis. Our results indicate that IL-23 contributes to the control of *H. pylori* infection and severity of gastritis, playing a role in the activation of the immune response and induction of gastritis in response to *H. pylori*.

Materials and Methods {#s1}
=====================

Animals
-------

Male and female IL-23+/− mice, on a mixed background (Strain name B6; 129S5-Il-23a^tm1Lex^/Mmcd) were obtained from the NIH Consortium (Stock number 011725-UCD MMRC, UC Davis) for the establishment of a breeding colony. The targeted mouse gene is *IL-23a* (interleukin 23, alpha subunit p19), an ortholog of human IL-23A. Other aliases of IL-23 include P19, SGRF, IL-23, IL-23A, IL-23P19, interleukin 23p19 subunit, and JKA3 induced upon T-cell activation. Coding exon 1 was targeted by homologous recombination. The IL23+/− breeding pairs tested negative for intestinal *Helicobacter*. *Helicobacter*-free male mice, 8--10 weeks old, were used in all experiments. The Vanderbilt University Institutional Animal Care and Use Committee approved all animal protocols used in this study. Feces from sentinel mice housed in the same room were routinely tested by PCR for intestinal *Helicobacter*, pinworms, mouse parvovirus, and several other murine pathogens, and consistently tested negative for each of these infections.

Culture of *H. pylori*
----------------------

A mouse-passaged derivative of *H. pylori* strain SS1 was used in all animal experiments. For cell culture experiments several strains were used, including PM-SS1, SS1, 60190, X47, 26695, and 7.13. Bacteria were grown on trypticase soy agar (TSA) plates containing 5% sheep blood. Alternatively, bacteria were grown in *Brucella* broth containing 10% heat-inactivated fetal bovine serum (FBS) and 10 μg/ml vancomycin. Cultures were grown at 37°C in either room air supplemented with 5% CO~2~, or under microaerobic conditions generated by a CampyPak Plus^\*^ Hydrogen + CO~2~ with Integral Palladium Catalyst (BD).

Bone marrow preparation
-----------------------

After CO~2~ euthanasia and cervical dislocation, femurs, and tibiae from male mice strains were separated from muscle tissue. Cleaned bones were collected in 50 ml conical tubes on ice with ice-cold PBS without calcium and magnesium (Cellgro by Mediatech, Manassas, VA, USA). Bones were washed by inverting the tube several times with 1X PBS and then followed by a wash with ice-cold RPMI 1640 media (Mediatech). Bone marrow was flushed from the bones with a 21G needle with ice-cold RPMI 1640. Aggregates within the bone marrow suspension were disrupted by pipetting until single cell suspensions were obtained. Single cell bone marrow suspension was passed through a sterile 70 μm nylon cell strainer (Fisherbrand, Pittsburgh, PA, USA) to remove remaining cellular debris. Bone marrow cells were pelleted by centrifugation, red blood cells were removed using water lysis, and bone marrow cells were then diluted 5× with ice-cold RPMI 1640, passed through a nylon strainer and then centrifuged. Viable bone marrow cells were enumerated and were adjusted to a concentration of 1 × 10^6^ cells/ml in complete RPMI 1640 medium supplemented with 5% heat-inactivated FBS (Atlanta Biologicals, Miami, FL, USA), 55 μM 2-mercaptoethanol, 1 mM sodium pyruvate (GIBCO), and 20 ng/ml mouse granulocyte-macrophage colony stimulating factor (GM-CSF) premium grade (Miltenyi Biotec, Boston, MA, USA). Cells were cultured in T75 tissue culture flasks at 37°C with 5% atmospheric CO~2~. After 3 days of culture, 10 ml of fresh complete medium containing GM-CSF were added to the flasks. On day 6 of culture, cells were resuspended by repeated pipetting and after washing, viable cells were enumerated as previously described.

Positive selection of CD11c bone marrow-derived dendritic cells by autoMACS
---------------------------------------------------------------------------

Bone marrow cells were magnetically labeled with CD11c Microbeads (Miltenyi Biotec). CD11c+ bone marrow derived dendritic cells (BMDCs) were positively selected using the positive selection sensitive program on the autoMACS machine (Miltenyi Biotec) according to manufacturer's protocol.

Bone marrow-derived dendritic cell co-culture with *H. pylori* strains
----------------------------------------------------------------------

Bone marrow derived dendritic cells were centrifuged at 200 × *g* for 10 min at 4°C, enumerated, and adjusted to a concentration of 2 × 10^6^ cells/ml in RPMI 1640 media supplemented with 5% heat-inactivated FBS, 55 μM 2-mercaptoethanol, and 1 mM sodium pyruvate. One milliliter, 2 × 10^6^ cells, were transferred into each well of a 24 well plate and incubated 1 h at 37°C with 5% atmospheric CO~2~ prior to infection with *H. pylori* strains. BMDCs were infected at a MOI of ∼50 with given *H. pylori* strains in duplicate or triplicate wells as indicated. To facilitate contact between BMDCs and *H. pylori*, the 24 well plate was centrifuged at 200 × *g* for 10 min at 4°C. Infected BMDCs were incubated at 37°C with 5% atmospheric CO~2~ for 6 h. After 6 h of culture cells were collected, resuspended in TRIZOL and RNA was isolated as described below for real-time rtPCR analysis. Alternatively, supernatants were collected from these cultures at 24 h. The supernatant medium was centrifuged and filtered. Supernatants were analyzed for expression of IL-23p19, IL-1β, IL-6, by using the Searchlight System (Aushon, Billerica, MA, USA).

Infection of mice with *H. pylori*
----------------------------------

One day prior to infection of mice, *H. pylori* from plate cultures were inoculated into liquid medium and were cultured for 18 h under microaerobic conditions, as described above. Mice were orogastrically inoculated with a suspension of 5 × 10^8^ CFU of *H. pylori* in 0.5 ml of *Brucella* broth. Mice were inoculated twice over 5 days.

Processing of mouse stomachs
----------------------------

The stomach was removed from each mouse by excising between the esophagus and the duodenum. The forestomach (non-glandular portion) was removed from the glandular stomach and discarded. The glandular stomach was opened, rinsed gently in cold PBS, and cut into three longitudinal strips that were used for bacterial culture, RNA analysis, and histology. For culturing of *H. pylori* from the stomach, gastric tissue was placed into *Brucella* broth-10% FBS for immediate processing. Gastric tissue was stored in RNALater (Ambion) solution for subsequent RNA isolation. A longitudinal strip from the greater curvature of the stomach was excised and placed in 10% normal buffered formalin for 24 h, embedded in paraffin and processed routinely for hematoxylin and eosin (H&E) staining. Indices of inflammation and injury were scored by a single pathologist (KW) who was blinded to the identity of the mice. Acute and chronic inflammation in the gastric antrum and corpus were graded on a 0-3 scale. Acute inflammation was graded based on density of neutrophils and chronic inflammation was graded based on the density of lamina propria mononuclear cell infiltration independent of lymphoid follicles. The total inflammation score is the sum of the chronic and acute inflammation scores in the antrum and the corpus.

Culture of *H. pylori* from mouse stomach
-----------------------------------------

Gastric tissue was homogenized using the Tissue Tearor (BioSpec Products, Bartlesville, OK, USA). Serial dilutions of the homogenate were plated on trypticase soy agar, containing 5% sheep blood, 10 μg/ml nalidixic acid, 100 μg/ml vancomycin, 2 μg/ml amphotericin, and 200 μg/ml bacitracin (all antibiotics were purchased from Sigma). After 5--7 days of culture under microaerobic conditions, *H. pylori* colonies were counted and the number of colony forming units per gram of tissue calculated (CFU/g).

RNA extraction and real-time rtPCR
----------------------------------

RNA was isolated from the stomach using the TRIZOL isolation protocol (Invitrogen, Carlsbad, CA, USA) with slight modifications. Stomach tissue was homogenized in 1 ml of TRIZOL reagent and then two chloroform extractions were performed. Following an isopropanol precipitation, the RNA was washed with 70% ethanol and treated with RNase Inhibitor (Applied Biosystems, Foster City, CA, USA) for 30 min. The RNA was resuspended at 65°C for 15 min and RNA preparations were further purified using the Qiagen RNA isolation kit as directed by the manufacturer (Qiagen Inc., Valencia, CA, USA). RNA was reverse transcribed using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). For real time rtPCR, we used the relative gene expression method (Giulietti et al., [@B17]). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) served as the normalizer, and tissue from uninfected mouse stomachs served as the calibrator. All cDNA samples were analyzed in triplicate, along with "no reverse transcriptase" controls, using an Applied Biosystems StepOne Plus real time PCR instrument. Levels of cytokine expression are indicated as "normalized expression," based on comparison of tissue from *H. pylori*-infected mice with tissue from uninfected mice (calibrator tissue; Giulietti et al., [@B17]). Relative units (or normalized expression) were calculated as 2\^−ΔΔCt (Ct, cycle threshold) where ΔΔCt is equal to the difference between the ΔCt of the gene of interest of the experimental sample and the ΔCt of the gene of interest of the calibrator tissue. The ΔCt of the gene of interest is calculated as the difference between the cycle threshold of the gene of interest and the cycle threshold of GAPDH (our normalizer). Primer and probe sets were purchased as Taqman Gene Expression Assays from Applied Biosystems \[IL-1β (accession number Mm00434227_g1), IL-6 (Mm99999064_m1), IL-10 (Mm01288386_m1), IL-12a (Mm00434165_m1), IL-17a (Mm00439619_m1), IL-23a (Mm01160011_g1), Foxp3 (Mm00475162_m1), GAPDH (Mm99999915_g1), IFNγ (Mm999 99071_m1)\].

Statistical analysis
--------------------

Four to six mice per group per time point were used for all of the studies. To compare results obtained with different groups of mice, statistical analysis was performed using an unpaired student's T test utilizing GraphPad Prism software. For analyses of bacterial numbers and cell numbers, the data were normalized by log transformation prior to statistical analysis. For histology scores, the Mann-Whitney U-test was applied to compare results between IL23+/+ and IL-23−/− mice.

Results
=======

IL-23p19 and Th17 inducing cytokines are stimulated in dendritic cells by *H. pylori*
-------------------------------------------------------------------------------------

The ability of DCs to sense infection and to differentially secrete both IL-12 and IL-23 are critical to the initiation of both Th1 and Th17 responses to pathogens. To determine whether Th17 inducing cytokines were upregulated in dendritic cells upon exposure to *H. pylori*, BMDC were generated from wild-type mice (both IL-23+/+ mice which are on a mixed background, and C57Bl/6 mice) and co-cultured with *H. pylori*. The results indicate that *H. pylori* co-culture with BMDCs induces mRNA expression of Th17 inducing cytokines, IL-1β and IL-6, and IL-23p19 (Figure [1](#F1){ref-type="fig"}A), which likely enhances IL-17 expression through a STAT3 dependent mechanism. The increase in IL-1β and IL-6, and IL-23p19 was confirmed using a protein based multiplex assay on supernatants from 24 h co-cultures (Figure [1](#F1){ref-type="fig"}C). Moreover, Th1 inducing cytokine, IL-12p40, and regulatory cytokine, IL-10, also increase in expression relative to untreated dendritic cells (Figure [1](#F1){ref-type="fig"}B). Several strains were used to investigate whether different virulence factors would influence the dendritic cell's cytokine response. For example PM-SS1 and SS1 were compared to investigate the influence of a functional type IV secretion system (the Cag pathogenicity island CagPAI). PM-SS1 (pre-mouse SS1) contains a functional CagPAI, whereas in SS1 the CagPAI is no longer intact. Our data indicate that the cytokine expression by the dendritic cells is independent of a functional CagPAI (Figures [1](#F1){ref-type="fig"}A,B). Several additional strains of *H. pylori* (including 26695, 60190, 7.13, and X47) were also used in this co-culture system and induce these cytokines in dendritic cells with no significant differences between the dendritic cell cytokine responses with these *H. pylori* strains (data not shown). Performing similar experiment to compare cytokine expression at 6 h of co-culture in IL-23+/+ verse IL-23−/− BMDC, we observed no consistent statistical differences in the expression of these cytokines (data not shown) with the exception of IL-23 which as expected was not detected in the IL-23−/− BMDC.

![**Dendritic cell co-cultures with *H. pylori***. When cultured with *H. pylori* strains SS1 or PM-SS1, bone marrow derived dendritic cells from wild-type mice produce **(A)**. Th17 influencing cytokines (IL-1β, IL-6, and IL-23a), **(B)**. Regulatory cytokine IL-10 and Th1 inducing cytokine IL-12. Real time rtPCR was performed to measure cytokine expression at 6 h of co-culture with and without *H. pylori*. Graphs are representative of four independent experiments. **(C)** Th17 influencing cytokines (IL-1β, IL-6, and IL-23a) protein levels in the supernatants from dendritic cell- *H. pylori* co-cultures at 24 h (units for each cytokine are noted on the *x*-axis).](fimmu-03-00056-g001){#F1}

IL-23p19 deficient mice carry higher *H. pylori* bacterial loads during chronic infection
-----------------------------------------------------------------------------------------

To investigate whether a deficiency in IL-23p19 leads to a change in the ability of the mice to control *H. pylori* colonization, we infected IL-23−/− mice and IL-23+/+ mice with *H. pylori* strain SS1 and followed the course of infection for up to 4 months. At 1 month post-infection, there was no significant difference in the bacterial burden in the IL-23−/− mice compared to the IL-23+/+ mice (data not shown). By 3 and 4 months post infection, the IL-23−/− mice did not control the bacterial burden as well as the IL-23+/+ mice (Figure [2](#F2){ref-type="fig"}).

![**Colonization of IL-23p19 deficient mice with *H. pylori***. IL-23−/− mice and IL-23+/+ littermates were infected with *H. pylori* strain SS1 for 3 and 4 months. Levels of colonization were measured by plating serial dilutions of stomach homogenates. The number of colony forming units (CFU) per gram of stomach tissue is presented on the graphs for 3 months post-infection **(A)** and 4 months post-infection **(B)**.](fimmu-03-00056-g002){#F2}

IL-23p19 is required for high levels of T helper cytokine expression during *H. pylori* infection
-------------------------------------------------------------------------------------------------

To determine whether IL-23p19 deficient mice have reduced expression of T cell derived cytokines, IL-17, and IFNγ, we performed real time rtPCR on stomach tissue of IL-23−/− and IL-23+/+ mice during chronic *H. pylori* infection. Our data indicate that *H. pylori* infected IL-23−/− mice have significantly reduced expression of IL-17 and IFNγ by 3 months post infection compared to *H. pylori* infected IL23+/+ mice (Figure [3](#F3){ref-type="fig"}).

![**Th17 and Th1 responses are reduced in *H. pylori* infected IL-23**−/− **mice compared to *H. pylori* infected IL-23+/+ mice**. Real time rtPCR was performed on stomach tissue of *H. pylori* infected mice. Relative units of IFNγ **(A)** and IL-17A **(B)** were measured at 3 months post-infection. Graphs are representative of three independent experiments.](fimmu-03-00056-g003){#F3}

To investigate whether the decrease in pro-inflammatory T cell cytokines was a result of an increase in T~reg~ cells, we assayed for expression of Foxp3 in the tissue. We were unable to detect any significant differences in expression of Foxp3 comparing *H. pylori* infected IL-23−/− mice and *H. pylori* infected IL-23+/+ mice at 3 or 4 months post infection (data not shown).

IL-23p19-deficient mice have minimal chronic gastritis
------------------------------------------------------

To investigate the impact of the IL-23 deficiency, increased bacterial burden and decreased T helper responses in the stomachs of the IL-23−/− mice on the inflammatory response, we scored the stomach tissue for both chronic and acute inflammation (see [methods](#s1){ref-type="sec"} for how these types of inflammation are defined). Our data indicate that there is no significant difference in total inflammation (sum of acute and chronic inflammation in the corpus and antrum) between IL-23−/− mice and IL-23+/+ mice (*p* = 0.0521; Figure [4](#F4){ref-type="fig"}A) at 3 months post infection. However, there is a significant decrease in the chronic inflammatory scores of *H. pylori*-infected IL-23−/− mice compared to *H. pylori* infected IL-23+/+ littermates at 3 months post infection (*p* = 0.0074; Figure [4](#F4){ref-type="fig"}B). At 4 months post infection, while there was a trend toward decreased total inflammation in the *H. pylori*-infected IL-23−/− mice compared to *H. pylori*-infected wild-type mice, the differences were not significant (*p* = 0.20, data not shown).

![**Inflammation is reduced in *H. pylori* infected IL-23**−/− **mice compared to *H. pylori* infected IL-23+/+ mice**. Levels of acute and chronic inflammation were scored on stomach tissue (in the corpus and antrum) at 3 months post infection. Total inflammation **(A)** was scored on a scale of 0--12. Chronic inflammation **(B)** in the corpus and antrum was scored on a scale of 0--6.](fimmu-03-00056-g004){#F4}

Peyer's patches from IL-23−/− mice have differential expression of IL-12p40
---------------------------------------------------------------------------

In a mouse model of infection it has been demonstrated that Peyer's patches are required for the development of gastritis in the stomach (Nagai et al., [@B32]). To investigate whether defective priming accounted for the reduced level of chronic inflammation observed in the IL-23 deficient mice, we measured the expression of cytokines known to influence T cell priming (IL-23p19, and IL-12p40) in the Peyer's Patches of both *H. pylori* infected IL-23−/− and IL-23+/+ mice. Moreover we measured expression of IFNγ, IL-17, and Foxp3 as a measure of Th responses in the Peyer's patches.

While expression of IL-17, IFNγ, and Foxp3 was similar in *H. pylori*-infected IL-23−/− and IL23+/+ mice during chronic infection (Figure [5](#F5){ref-type="fig"}A), the levels of IL-12p40 were significantly higher (relative to uninfected wild type mice) in IL-23−/− mice when compared to IL-23+/+ mice (Figure [5](#F5){ref-type="fig"}B). Analysis of IL-12p40 gene expression in the stomach and in the spleen was similar in *H. pylori* infected IL-23−/− and *H. pylori* infected IL-23+/+ mice (Figure [5](#F5){ref-type="fig"}B). To investigate whether differences in baseline expression of IL-12p40 mRNA accounted for this difference in the Peyer's patches, we measured IL-12p40 mRNA expression in uninfected IL-23−/− v. uninfected IL-23+/+. The data indicate that IL-23−/− mice exhibit about twofold higher levels of IL-12 than uninfected IL-23+/+ mice (data not shown).

![**Peyer's patches express T cell skewing cytokines during chronic infection**. Levels of Foxp3, IFNγ, and IL-17A **(A)**, IL-12p40 **(B)** were measured by real time rtPCR at 3 and 4 months post infection. Normalized expression also known as relative units are the relative expression calibrated to uninfected wild-type with GAPDH as the endogenous control. Due to differences in IL-12p40 in the Peyer's patches, IL-12p40 expression was also measured in the spleen and gastric mucosa **(B)**.](fimmu-03-00056-g005){#F5}

Discussion
==========

The T helper response, which develops toward *H. pylori* infection, is a mixed response. The level of gastritis and bacterial colonization may be dependent on the balance between Th1, Th17, and T~reg~ responses. Because Th1 and Th17 cells likely contribute to protective immunity to *H. pylori*, understanding the contributions of cytokines produced by innate immune responses which influence the T helper responses is of great interest to understanding this balance. Our study specifically investigated the contribution of IL-23 on the development of T cell responses and gastritis.

IL-23 drives intestinal pathology in experimental models of T cell-dependent and innate colitis (Hue et al., [@B20]; Kullberg et al., [@B25]; Uhlig et al., [@B41]; Yen et al., [@B45]; Elson et al., [@B15]); therefore we hypothesized that it would also drive *H. pylori*-induced pathology in the stomach. Our studies on BMDCs indicate that culture of dendritic cells with *H. pylori* (at an MOI of 50) leads to increased expression of IL-23, IL-1β, IL-6, IL-12, and IL-10 by 6 h post infection. We have observed the increased expression of these cytokines with several strains of *H. pylori* suggesting that the major determinants of dendritic cell activation are not dependent on the CagPAI or VacA since these strains vary in their expression of the Type IV secretion system and express various isoforms of the vacuolating toxin, VacA (if any). These data are consistent with data published by Kao et al. ([@B21]) which indicated that CagA deletion did not affect the T~reg~ skewing of *H. pylori* treated-DCs. Contrary to our results, Tanaka et al. ([@B40]) present data which suggests the presence of CagA contributes to regulation of cytokine production in DCs co-cultured with *H. pylori*.

In the mouse model of infection, our data suggests that IL-23 makes a minor contribution to the development of chronic gastritis in this model of *H. pylori* infection. For instance, differences in gastritis were only observed at chronic time points (3 and 4 months post infection) and in chronic inflammation (when data is stratified, no differences were observed in acute inflammation).

It is clear that IL-23 plays a role in expanding and maintaining the Th17 subset of CD4+ T helper cells. In addition, there is evidence in mouse models of *M. tuberculosis* and *H. hepaticus* that IL-23 is involved in inducing IFNγ production by CD4+ T-cell (Khader et al., [@B22]; Kullberg et al., [@B25]). Our studies indicate that IL-23 makes a contribution to both Th1 and Th17 responses during *H. pylori* infection especially during the chronic stage of infection. By 3 months post infection, IL-23−/− mice have significantly reduced IL-17 and IFNγ expression compared to *H. pylori* infected wild-type mice. It is important to recognize that Th17 cells are likely still developing in these IL-23−/− mice, but overall expression of IL-17a is lower. We were unable to detect differences in neither IL-21 nor IL-17f in these studies (data not shown). Due to the increased bacterial burden in the stomachs of IL-23−/− mice compared to wild-type mice, we speculate that chronic bacterial exposure in conjunction with ongoing stimulation of antigen presenting cells and continual expression of IL-1β, IL-6, and TGFβ would drive Th17 differentiation even in the absence of IL-23 expanding and maintaining the population of cells.

IL-23 has been reported to inhibit the accumulation of Foxp3+ T~regs~ in the intestines. IL-23 receptor deficient (IL-23R−/−) T cells adoptively transferred into Rag−/− recipients demonstrate an increased ability to develop into T~regs~ compared to wild-type T cells adoptively transferred into Rag−/− recipients. Moreover, there is evidence that IL-23 may inhibit IL-10 production. To investigate the effects of IL-23 on the development of T~regs~ in our mouse model of *H. pylori* infection, we measured Foxp3 expression in both the stomach and the Peyer's patches. Our data indicate there is no significant difference in expression of Foxp3 comparing *H. pylori* infected IL-23−/− and wild-type mice.

Our findings that the levels of chronic inflammation were significantly reduced in the *H. pylori* infected IL-23−/− mice compared to *H. pylori* infected wild-type mice has led us to question how efficient priming is in the IL-23−/− mice. Unfortunately, this is a very difficult question to answer with few defined antigens for *H. pylori*. Based on the evidence that in the absence of Peyer's patches there is no gastritis (Nagai et al., [@B32]), we focused on this site to investigate the activation of innate T helper driving cytokines, IL-12 and IL-23, and measured expression of Foxp3 as a marker for T~reg~ development. Our findings suggest that in the absence of IL-23, there may be an increase in the baseline expression (in uninfected mice) of IL-12, which suggests that there may be inherited differences in the ability of these mice to develop Th1 responses. We would have expected IL-23−/− mice to have lower IL-12 in the Peyer's patches since their Th1 responses are depressed in the gastric mucosa. Previously, Becker et al. ([@B2]) demonstrated that IL-23 can downregulate TLR-induced IL-12 expression suggesting that IL-23 can indirectly inhibit Th1 responses, but our data suggests that in the absence of IL-23, both Th1 and Th17 responses are depressed in the gastric mucosa. We speculate that while the Peyer's patches may be a site for T cell priming a potential surrogate marker for what is happening in the gastric mucosa, primed T cells must still receive the correct signals to migrate into the gastric mucosa from the Peyer's patches. Therefore, IL-23 and the Th17 response may be necessary for inflammation to initiate a cascade of chemokines which would then also recruit Th1 cells to the site of infection.

The study was performed on mice which were obtained from the NIH Consortium and they are described as B6:129 mice, therefore they are on a mixed background. We used wild-type littermates as controls for the IL-23−/− mice. The B6:129 mice exhibit a milder gastritis response compared to C57Bl/6 mice (total inflammatory scores are often higher in WT C57Bl/6 mice than these B6:129 WT mice, Algood et al., [@B1]). We also observed more variation within groups which may be a result of the mixed background of the mice. While it may be somewhat cumbersome, there is a need for a study which would experimentally measure T cell priming and activation in various secondary lymphatic tissues over time, with multiple strains of *H. pylori*, in several strains of inbred mice. It is likely that the differences in inflammation observed in mice of different backgrounds could be correlated with differences in the magnitude of T cell priming in the lymphatics, the ratio of Th1:Th17:T~reg~ development, and the timing of the response.

In this study in particular, we have demonstrated that IL-23 plays a minor role in control of *H. pylori* induced gastritis. Reduced chronic inflammation correlates with reduced Th17 and Th1 cytokine expression in the stomachs of the *H. pylori*-infected IL-23−/− mice compared to wild-type mice. In future studies, it will be of interest to investigate T cell priming early during infection and the role IL-23 plays at the sites of priming.
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